Todd Ridky

Linnaeus Therapeutics LLC is a development-stage biotech company that identifies and develops small molecule agents for the treatment of various cancers. The private company is based in Philadelphia, PA. The company's compounds can be used to increase or decrease pigmentation and provide a UV-protecting tan without DNA damage. The company was founded in 2016 by Christopher Natale, Todd Ridky, and the CEO is Patrick T. Mooney. The company also focuses on modulating melanocyte pigmentation to correct genetic and acquired skin pigmentation conditions.

Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ.